Disclosure of a transparency notification from Aberdeen Group plc
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 20 March 2026 – 6 PM…
Tecan to create Data-Driven Labs with NVIDIA
Männedorf, Switzerland, March 17, 2026 – The Tecan Group (SIX Swiss Exchange:…
Fagron publishes its Annual Report 2025
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 March 2026 7AM CET Fagron publishes…
Press Release: Sanofis Board of Directors proposes the appointment of Christel Heydemann as an independent director
Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director …
Press Release: Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season
Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants…
Vistin Pharma ASA: Fourth quarter and preliminary 2025 financial results
Oslo, Norway, 12th of February 2026 Vistin Pharma ASA (VISTN) today announces…
Bavarian Nordic Reports Preliminary 2025 Financial Results and Provides Guidance for 2026
Exceeding latest 2025 guidance following a strong performance from both commercial arms…
Tecan to host Analyst and Media Conference with Capital Markets Update on March 16, 2026
Männedorf, Switzerland, February 10, 2026 – The Tecan Group (SIX Swiss Exchange:…
Press Release: Sanofis Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease
Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic…
Press Release: Sanofi and Regenerons Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma
Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to…
